期刊文献+

低分子量肝素——速避凝预防玻璃体切除术后眼内纤维蛋白渗出 被引量:8

Low molecular weight heparin (fraxiparine)for prevention of experimental postvitrectomy intraocular fibrin
原文传递
导出
摘要 目的观察低分子量肝素——速避凝对兔眼玻璃体切除术后眼内纤维蛋白渗出的预防效果。方法青紫蓝兔14只随机分为两组,均进行标准的晶体粉碎切割及中央玻璃体切除,盲法给予灌注液,对照组为平衡盐液,实验组为平衡盐液中加入速避凝,浓度为6U/ml,观察术后眼内纤维蛋白渗出及术中、术后眼内出血情况。结果实验组术后第一至第三天眼内纤维蛋白渗出均明显轻于对照组(P<0.01);眼内纤维蛋白渗出平均清除时间也较对照组短(P=0.001),两组术中及术后眼内出血情况无显著差异。结论低分子量肝素——速避凝可有效地预防玻璃体切除后眼内纤维蛋白的形成,并且不增加眼内出血的危险性。 Purpose To determine the efficacy of a low molecular weight heparin(fraxiparine)administered in the infusion fluid to prevent postoperative fibrin formation in a rabbit lensectomy and vitrectomy model. Methods Fourteen adult pigmented rabbits were randomly assigned into two groups.Standard fragmatome lensectomies and core vitrectomies were performed prospectively in a masked fashion on control eyes with balanced salt infusion and on experimental eyes treated with fraxiparine/ml 6U in the infusate.Intraoperative bleeding was graded in a masked fashion by the surgeon.The amounts of fibrin and hemorrhage were graded in a masked fashion on postoperative days 1 through 7. Results The mean grde of fibrin in the eyes treated with fraxiparine was lower than that in the control eyes(P<0.01)on postoperative days 1 through 3 respectively.Also,the average days to clear the fibrin in the eyes treated with fraxiparine was shorter than that in the control eyes(P=0.001).No statistically significant differences in the degree of intraoperative or postoperative hemorrhage were noted between the two groups. Conclusion Low molecular weight heparin(fraxiparine)is an effetive inhibitor of postoperative fibrin formation in a rabbit model and is not associated with an increased risk of intraoperative or postopertive bleeding at the tested dose.
出处 《中华眼底病杂志》 CAS CSCD 北大核心 1998年第1期35-37,共3页 Chinese Journal of Ocular Fundus Diseases
关键词 玻璃体切除 纤维蛋白溶解 肝素 低分子量 Vitrectomy Fibrinolysis Exudates and transudates Heparin, low molecular weight/therapeutic use
  • 相关文献

参考文献6

  • 1Barraowcliffe TW,Annotation:Low molecular weight heparin(s).Br J Haematol,1995,90:1-9.
  • 2Iverson DA,Katsura H,Hartzer MK,et al.Inhibition on intraocular fibrin formation following infusion of low-molecular weight heparin during vitrectomy.Arch Ophthalmol,1991,109:405-409.
  • 3Jaffe GJ,Schwartz D,Han DP,et al.Risk factors for postvitrectomy fibrin formation.Am J Ophthalmol,1990,109:661-667.
  • 4Jaffe GJ,Abrams GW,Williams GA,et al.Tissue plasminogen activator for postvitrectomy fibrin formation.Ophthalmology,1990,97:184-189.
  • 5Johnson RN,Blankenship G,A Prospective,randomized,clinical trial of heparin therapy for postoperative intraocular fibrin.Ophthalmology,1988,95:312-317.
  • 6Chapman C,Iverson D,Hartzer M,et al.The effect of low molecular weight heparin on proliferative vitreoretinopathy induced in the rabbit eye.Invest Ophthalmol Vis Sci,1992,33(Suppl):818.

同被引文献36

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部